|
English
|
正體中文
|
简体中文
|
2817580
|
|
???header.visitor??? :
27786310
???header.onlineuser??? :
775
???header.sponsordeclaration???
|
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"chiun hsu"???jsp.browse.items-by-author.description???
Showing items 1-10 of 356 (36 Page(s) Totally)
1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page
| 臺大學術典藏 |
2022-09-08T07:35:35Z |
Fully digital problem-based learning for undergraduate medical students during the COVID-19 period: Practical considerations
|
Chao, Chia-Ter; Tsai, Chiao-Lin; Lin, Mong-Wei; Yang, Chih-Wei; CHAO-CHI HO; Chen, Huey-Ling; CHIUN HSU; Sheu, Bor-Ching |
| 臺大學術典藏 |
2022-09-08T07:29:51Z |
Effectiveness of tutor shadowing on faculty development in problem-based learning
|
Tsai, Chiao-Ling; Chiu, Yen-Lin; Chao, Chia-Ter; Lin, Mong-Wei; CHAO-CHI HO; Chen, Huey-Ling; Sheu, Bor-Ching; CHIUN HSU; Yang, Chih-Wei |
| 臺大學術典藏 |
2022-08-19T00:21:17Z |
A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil
|
Yeh K.-H.; Bu C.-F.; Lin C.-C.; Lu Y.-S.; Yang C.-H.; CHIUN HSU; Cheng A.-L.; Hsu C.-H. |
| 臺大學術典藏 |
2022-08-19T00:21:17Z |
HER-2/neu overexpression is rare in hepatocellular carcinoma and not predictive of anti-HER-2/neu regulation of cell growth and chemosensitivity
|
Cheng A.-L.; Wang S.-J.; Lee P.-H.; Huang C.-L.; Hsu H.-C.; CHIUN HSU |
| 臺大學術典藏 |
2022-08-19T00:21:16Z |
Survival-weighted health profile for long-term survivors of acute myelogenous leukemia
|
Tang J.-L.; Chen Y.-C.; Cheng A.-L.; Chang S.-M.; Tien H.-F.; Hwang J.-S.; Wang J.-D.; CHIUN HSU |
| 臺大學術典藏 |
2022-08-19T00:21:16Z |
Using standardised measures of health-related quality of life: Critical issues for users and developers
|
Kind P.; CHIUN HSU; Wang J.-D.; Yao G.; Tang J.-L. |
| 臺大學術典藏 |
2022-08-19T00:21:16Z |
Phase II trial combining paclitaxel with 24-hour infusion cisplatin for chemotherapy-na?ve patients with locally advanced or metastatic breast carcinoma
|
Cheng A.-L.; Chang K.-J.; Chen M.M.; Lu Y.-S.; Bu C.-F.; CHIUN HSU; Huang C.-S.; Chao T.-Y. |
| 臺大學術典藏 |
2022-08-19T00:21:16Z |
Low-dose thalidomide treatment for advanced hepatocellular carcinoma
|
CHIUN HSU; Chen C.-N.; Chen L.-T.; Wu C.-Y.; Yang P.-M.; Lai M.-Y.; Lee P.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2022-08-19T00:21:15Z |
Lack of efficacy of troglitazone at clinically achievable concentrations, with or without 9-cis retinoic acid or cytotoxic agents, for hepatocellular carcinoma cell lines
|
Shen Y.-C.; CHIUN HSU; Chen J.-Y.; Cheng A.-L. |
| 臺大學術典藏 |
2022-08-19T00:21:15Z |
Recent advances in non-surgical treatment for advanced hepatocellular carcinoma
|
CHIUN HSU; Cheng J.C.-H.; Cheng A.-L. |
Showing items 1-10 of 356 (36 Page(s) Totally)
1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page
|
